Long-term effects of aripiprazole and haloperidol on affective symptoms of schizophrenia

被引：0
|
作者：
Stock, E
Archibald, DG
Tourkodimitris, S
Kujawa, M
Marcus, R
Carson, W
Iwamoto, T
机构：
[1] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
[2] Bristol Myers Squibb Co, Princeton, NJ USA
[3] Otsuka Amer Pharmaceut Inc, Princeton, NJ USA
[4] Otsuka Pharmaceut Co Ltd, Tokyo, Japan
来源：
SCHIZOPHRENIA RESEARCH | 2004年 / 67卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：158 / 159
页数：2
相关论文
共 50 条
  • [41] Cost/effectiveness of aripiprazole vs. olanzapine in the long-term treatment of schizophrenia
    Dutina, Aleksandra
    Stasevic-Karlicic, Ivana
    Pandrc, Nicola
    Prokic, Andelka
    Jankovic, Slobodan M.
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2019, 147 (7-8) : 468 - 474
  • [42] Negative symptoms and their association with depressive symptoms in the long-term course of schizophrenia
    an der Heiden, Wolfram
    Leber, Anne
    Haefner, Heinz
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2016, 266 (05) : 387 - 396
  • [43] Efficacy of aripiprazole-IM-depot for long-term maintenance treatment of schizophrenia
    Kane, J.
    Sanchez, R.
    Perry, P.
    Jin, N.
    Johnson, B.
    Forbes, R. A.
    McQuade, R. D.
    Carson, W. H.
    Fleischhacker, W.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 119 - 119
  • [44] Negative symptoms and their association with depressive symptoms in the long-term course of schizophrenia
    Wolfram an der Heiden
    Anne Leber
    Heinz Häfner
    European Archives of Psychiatry and Clinical Neuroscience, 2016, 266 : 387 - 396
  • [45] Long-term symptomatic remission in patients with schizophrenia treated with aripiprazole or haloperidol: Results of a 52-week, double-blind, randomized study
    Kane, J. M.
    Swyzen, W.
    Wu, X.
    McQuade, R.
    Gutierrez-Esteinou, R.
    Tran, Q. -V
    Marcus, R. N.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S275 - S276
  • [46] Quetiapine versus haloperidol decanoate for long-term treatment of schizophrenia and schizoaffective disorder
    Glick, ID
    Marder, SR
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S162 - S162
  • [47] The prevalence of hyperprolactinemia after long-term haloperidol use in patients with chronic schizophrenia
    Jeong, CY
    Conley, RR
    Kelly, DL
    Shim, JC
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (06) : 613 - 615
  • [48] Haloperidol versus second-generation antipsychotics in the long-term treatment of schizophrenia
    Buoli, Massimiliano
    Kahn, Rene S.
    Serati, Marta
    Altamura, A. Carlo
    Cahn, Wiepke
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2016, 31 (04) : 325 - 331
  • [49] Quetiapine versus haloperidol decanoate for long-term treatment of schizophrenia and schizoaffective disorder
    Glick, I
    Marder, SR
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 484 - 484
  • [50] Efficacy and safety of aripiprazole and haloperidol in patients with schizophrenia
    Sulejmanpasic-Arslanagic, G.
    Kapetanovic, D.
    Srebrenka, B.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S490 - S491
12345